BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $542,075 | -21.6% | 10,794 | -1.3% | 0.00% | – |
| Q2 2023 | $691,155 | +43.8% | 10,936 | +2.4% | 0.00% | – |
| Q1 2023 | $480,471 | +28.2% | 10,680 | +24.8% | 0.00% | – |
| Q4 2022 | $374,816 | +19.7% | 8,556 | +80.3% | 0.00% | – |
| Q3 2022 | $313,000 | +24.7% | 4,746 | +102.2% | 0.00% | – |
| Q4 2021 | $251,000 | +5.0% | 2,347 | +0.8% | 0.00% | – |
| Q3 2021 | $239,000 | -86.9% | 2,328 | -87.6% | 0.00% | -100.0% |
| Q1 2021 | $1,829,000 | +482.5% | 18,809 | +571.0% | 0.00% | – |
| Q4 2020 | $314,000 | 0.0% | 2,803 | -17.2% | 0.00% | – |
| Q3 2020 | $314,000 | +37.7% | 3,384 | +15.6% | 0.00% | – |
| Q2 2020 | $228,000 | -17.1% | 2,928 | -14.6% | 0.00% | -100.0% |
| Q4 2019 | $275,000 | +16.5% | 3,428 | +6.9% | 0.00% | – |
| Q3 2019 | $236,000 | -74.5% | 3,207 | -67.3% | 0.00% | -100.0% |
| Q2 2019 | $925,000 | +201.3% | 9,810 | +156.1% | 0.00% | +100.0% |
| Q1 2019 | $307,000 | -25.3% | 3,830 | -27.2% | 0.00% | 0.0% |
| Q3 2018 | $411,000 | – | 5,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |